We aimed to examine the association between BMI and the risk of death from pancreas cancer in a pooled analysis of data from the Asia Cohort Consortium. The data for this pooled analysis included 883 529 men and women from 16 cohort studies in Asian countries. Cox proportional-hazards models were used to estimate the hazard ratios and 95% confidence intervals for pancreas cancer mortality in relation to BMI. Seven predefined BMI categories (< 18.5, 18.5-19.9, 20.0-22.4, 22.5-24.9, 25.0-27.4, 27.5-29.9, Z 30) were used in the analysis, with BMI of 22.5-24.9 serving as the reference group. The multivariable analyses were adjusted for known risk factors, including age, smoking, and a history of diabetes. We found no statistically significant overall association between each BMI category and the risk of death from pancreas cancer in all Asians, and obesity was unrelated to the risk of mortality in both East Asians and South Asians. Age, smoking, and a history of diabetes did not modify the association between BMI and the risk of death from pancreas cancer. In planned subgroup analyses among East Asians, an increased risk of death from pancreas cancer among those with a BMI less than 18.5 was observed for individuals with a history of diabetes; hazard ratio = 2.01 (95% confidence interval: 1.01-4.00) (P for interaction = 0.07). The data do not support an association between BMI and the risk of death from pancreas cancer in these Asian populations.
Introduction
Pancreas cancer is one of the most aggressive malignancies in humans, with an all-stage 5-year survival of less than 10% (Edwards et al., 2005) . According to Globocan, pancreas cancer was diagnosed in an estimated 107 810 Asian men and women in 2008 and a similar number (98 214) died from the disease (Ferlay et al., 2010) . Although this cancer used to be rare in Asia, incidence rates in East Asia have been increasing over the past decades and now approximate those in Europe and North America (Ferlay et al., 2010) .
Epidemiologic studies have clearly shown that cigarette smoking and long-standing type-II diabetes are associated with an increased risk of pancreas cancer (Iodice et al., 2008; Ben et al., 2011) . There is also mounting evidence for an association with being overweight or obese (Calle and Kaaks, 2004) . Statistically significant, positive associations have been observed in large cohort studies carried out in western countries (Michaud et al., 2001; Calle et al., 2003; Rapp et al., 2005) , and corroborated in at least four meta-analyses (Berrington de Gonzalez et al., 2003; Larsson et al., 2007; Renehan et al., 2008; Aune et al., 2012) and three pooled analyses (Arslan et al., 2010; Jiao et al., 2010; Genkinger et al., 2011) . The mechanisms by which obesity confers an increased risk are not well understood. Because obesity is closely related to insulin resistance and hyperinsulinemia and because high fasting serum glucose and insulin levels have been shown to predict the risk of pancreas cancer in diverse ethnic populations (Gapstur et al., 2000; Jee et al., 2005; Stolzenberg-Solomon et al., 2005) , insulin resistance and hyperinsulinemia are believed to play a central role (Khandekar et al., 2011) .
On the basis of a review of the literature, the World Cancer Research Fund concluded that the evidence that greater body fatness is a cause of pancreas cancer is convincing (World Research Fund, 2007) . It is worth noting, however, that this conclusion was based on the summary of findings mainly from cohort studies carried out in western countries; very few Asian studies were included. The observed differences in body fat distribution, genetic predisposition to obesity, and background lifestyle factors between Caucasians and Asians (Wen et al., 2012) indicate that the association between BMI and pancreas cancer may differ by ethnic group. To date, four cohort studies have examined the BMI-pancreas cancer associations in Asians, but the results have been inconsistent and inconclusive (Kuriyama et al., 2005; Lin et al., 2007; Luo et al., 2007; Jee et al., 2008) .
Given the plausible mechanisms underlying an obesitypancreas cancer association and the paucity of data from Asian populations, we examined the relationship in a pooled analysis of data from the Asia Cohort Consortium (ACC), which involved 883 529 men and women. This pooled analysis allowed us to estimate the risk of death from pancreas cancer in relation to finer BMI categories than would be feasible within any single study.
Methods

Study population
ACC is a consortium of cohort studies in Asian countries, the primary purpose of which is to explore the relationships among genetics, environmental exposures, and the etiology of disease. The details on the initiation and conduct of the ACC have been described elsewhere Zheng et al., 2011) . The ACC has recruited 19 cohorts to date. Sixteen cohorts provided information on death from pancreas cancer during follow-up as well as data on BMI, cigarette smoking, and a history of diabetes at baseline; these cohorts were included in this pooled analysis. Of these cohorts, eight are in Japan, two in China, one in Taiwan, two in Korea, two in India, and one in Bangladesh. For this pooled analysis, we excluded 50 421 individuals with missing data on age, sex, cigarette smoking, and/or BMI. Individuals who had a previous cancer diagnosis at baseline, those who had a BMI more than 50 or less than 15, and those with invalid or missing data on survival were excluded also. The final study population included 799 542 individuals.
This study was approved by the ethics committee overseeing each of the participating cohort studies and by the IRB at the Fred Hutchinson Cancer Research Center.
Exposure measurement and outcome ascertainment
In the majority of the ACC participating cohorts, both height and weight at baseline were self-reported. Outcomes for pancreas cancer mortality were ascertained from the causes of death recorded on death certificates. Information on cigarette smoking, a history of diabetes, and other lifestyle factors was collected at baseline.
Statistical analysis
We quantified the association between BMI and the risk of death from pancreas cancer on the basis of a meta-analysis of individual data from each cohort and a pooled analysis of aggregated data from all participating cohorts. For the metaanalysis, hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated for each cohort, and a random-effects model was adopted to calculate a summary HR by combining cohort-specific HRs (DerSimonian and Laird, 1986) . BMI was modeled categorically, using seven predefined BMI categories (< 18.5, 18.5-19.9, 20.0-22.4, 22.5-24.9, 25.0-27.4, 27.5-29.9, Z 30) . Individuals with BMIs of 22.5-24.9 served as the reference category because this BMI category has been shown to be associated with the lowest risk of all-cause mortality in East Asian populations (Jee et al., 2006; Sasazuki et al., 2011; Chen et al., 2012) . Between-study heterogeneity was estimated by a likelihood ratio test. In the pooled analysis, Cox proportionalhazards models were used to estimate HRs and 95% CIs for pancreas cancer mortality in relation to BMI.
The proportional hazards assumption was tested using Schoenfeld residuals.
In the absence of between-study heterogeneity, we present the results from the pooled analysis. The multivariable analyses were adjusted for known risk factors for pancreatic cancer, including age, smoking, and a history of diabetes.
Given the differences in genetic background and lifestyle factors as well as pancreas cancer rates, separate analyses were carried out for the East Asian population (Chinese, Japanese, and Korean) and the South Asian population (Indian and Bangladeshi populations). Results are presented for men and women combined, as well as separately. We show the results only for all men and women for the South Asian cohorts because they had a short follow-up period and a very small number of pancreas cancer deaths (31 of all 1489 deaths).
In addition, we carried out analyses stratified by age (< 55 years, Z 55 years), smoking status (never, former, current), and a history of diabetes (yes, no) to examine whether these factors modified the associations between BMI and the risk of pancreas cancer mortality. To examine the significance of interaction, we divided the patients into two BMI groups: less than 18.5 and 18.5 or more, and then generated a cross-product term in the model. We used a likelihood ratio to test the statistical significance of interaction. As a sensitivity analysis, we also excluded all deaths occurring in the first 3 years of follow-up to address the possibility that BMI variation was the result of disease rather than vice versa.
All analyses were carried out using R (version 2.11.1) (http:// www.r-project.org/). All statistical tests were two-sided. Table 1 presents the characteristics of the participating cohorts in the ACC. The mean follow-up period ranged from 3.1 to 22.0 years and the mean age at entry ranged from 36.8 to 59.5 years. The mean BMI ranged from 19.9 to 23.7. Of 1489 pancreas cancer deaths, 1458 (98%) were observed in East Asia. Table 2 shows the HRs and 95% CIs for pancreas cancer deaths in relation to BMI categories among all Asians, East Asians, and South Asians. In all Asians and East Asians, there were no statistically significant associations between BMI and the risk of death from pancreas cancer in either men or in women. In South Asians, those both underweight and overweight were at an increased risk of death from pancreas cancer; individuals with a BMI of 27.5-29.9 had a 4.9-fold increased risk compared with those with a BMI of 22.5-24.9. Table 3 shows the results of subgroup analyses stratified by age, smoking status, and diabetes among East Asians. There were no associations between obesity and the risk of death from pancreas cancer in current smokers, ex-smokers, or nonsmokers. In planned analyses stratified by diabetes, we observed a statistically significantly increased risk of death associated with low BMI (< 18.5) among individuals with a history of diabetes; the HR was 2.01 (95% CI: 1.01-4.00; P for interaction = 0.07). There were no associations between BMI and the risk of death from pancreas cancer among those without a history of diabetes. For both East Asian men and women, the risk estimates remained unchanged after excluding deaths that occurred within the first 3 years of follow-up. Additional adjustment for marital status and education in the multivariate model did not materially alter the results (data not shown).
Results
Discussion
In this pooled analysis of 799 542 Asian men and women, we found no overall associations between BMI and the risk of death from pancreas cancer in Asian populations. The findings were also null when we restricted the analyses to men and women who had never smoked or those who had no history of type-II diabetes.
Epidemiologic research has been inconclusive on the association between BMI and pancreas cancer in Asians.
No statistically significant increase in the risk of pancreas cancer among the obese was observed in the Japan Collaborative Cohort (JACC) study (Lin et al., 2007) and the Japan Public Health Center-based (JPHC) study (Luo et al., 2007) , two representative Japanese cohort studies, and also cohorts participating in the ACC.
In another cohort study carried out in Miyagi Prefecture (Kuriyama et al., 2005) , the obesity-pancreas cancer associations could not be quantified because no deaths had occurred in the BMI category of 30 or more. In a prospective study of over one million Koreans, the risk of pancreatic cancer was statistically significantly elevated in women who were either overweight or obese; however, no association was observed in men (Jee et al., 2008) . In China, although a previous case-control study had suggested a positive association between BMI and pancreas cancer (Ji et al., 1996) , no prospective cohort data have been available to examine this association. The available data, together with findings in the present study, do not support a role for obesity in the risk of pancreas cancer in East Asians. It is worth noting that the individual Asian cohort studies may have been underpowered to detect a small-to-moderate association because of very few individuals in the obese category. We, therefore, sought to overcome this limitation by pooling the data from 16 cohort studies across Asian countries, the majority of which are from East Asia; the results remained null. Consistent with our results, a pooled analysis of 424 519 participants in the Asia-Pacific Cohort Studies Collaboration found no increase in the risk of pancreas cancer among obese Asians (Parr et al., 2010) . For South Asians, although the results suggested an increase in risk among underweight and overweight individuals, the number of pancreas cancer deaths was too small to draw any firm conclusions. Given a potentially high level of misclassifications for pancreas cancer mortality, improving diagnostic accuracy is also an important issue in further studies. With extended follow-up and improved outcome ascertainment, further studies in these cohorts with a larger sample will be able to better quantify the association in South Asians.
There are several potential explanations for the null findings on the BMI-pancreas cancer association in Asian populations. The main reason may be the very small proportion of obese individuals in Asia. Although this pooled analysis included the largest number of Asians, the obese accounted for only 2.5%, much lower than that (B16-20%) in the pooled analyses of western cohort studies (Jiao et al., 2010; Genkinger et al., 2011) . The null findings could also be because of the differences in body fat distribution, in genetic predisposition to obesity, and in lifestyle factors between Caucasians and Asians (Wulan et al., 2010; Wen et al., 2012) . For example, diet is believed to play an important role in the development of pancreas cancer and the interaction of BMI with diet is possibly different between Caucasians and Asians. This issue needs to be addressed in additional studies. Finally, we could not exclude the possibility that some heterogeneity may still exist among the participating cohorts, although data were harmonized at the coordinating center using a standardized method and we found no between-study heterogeneity.
An interesting finding is that individuals who had a history of diabetes and a lower BMI were at a two-fold increased risk for pancreas cancer. Long-standing diabetes has been linked to an increased risk of pancreas cancer in numerous epidemiologic studies, including those from Japan and Korea (Ben et al., 2011) . Because the insulin resistance and hyperinsulinemia that characterize diabetes can be either causes or consequences of pancreas cancer, it is difficult to disentangle the complex association among BMI, diabetes, and the risk of pancreas cancer. A recent pooled analysis of ACC cohort studies has shown that both low BMI and high BMI are associated with an increased risk of all-cause mortality in all East Asian populations (Zheng et al., 2011) . There is also evidence suggesting that Asian individuals are more susceptible to insulin resistance at a lesser degree of obesity than individuals of European descent (Wulan et al., 2010) . This might increase the likelihood that, indeed, low BMI and diabetes act synergistically in the development of pancreatic cancer in this population. However, this was a subgroup analysis and chance remains a plausible explanation for the results.
Our study has several strengths. With the largest number of diverse Asian populations included in this pooled analysis, we were able to examine the association of pancreas cancer mortality with narrow BMI categories.
In addition, we carried out analyses stratified by sex, age, smoking status, and diabetes to examine whether these factors modify or confound the BMI-pancreas cancer association.
We recognize several limitations of our study. First, misclassification derived from collection of exposure data may be a concern. The validity of self-reported BMI data can be questioned in some East Asian cohorts. However, we consider that this may not drastically bias the results because our previous study has shown a similar pattern of association between BMI and death from any cause when either self-reported or measured data on height and weight were used (Zheng et al., 2011) . Some nondifferential misclassification may be present because BMI was not updated during the follow-up period. Second, information on pancreas cancer mortality was confirmed solely by death certificates in the majority of the ACC participating cohorts. This may have led to some misclassification of outcome. Third, few participating cohorts included in this pooled analysis measured waist circumference or the waist-hip ratio, which may be a better index for adiposity than BMI in the elderly (Biggs et al., 2010) . Cohort studies have shown that waist circumference and the waist-hip ratio are associated with a risk of pancreas cancer in Caucasians (Berrington de González et al., 2006; Stolzenberg-Solomon et al., 2008) ; however, very few studies are available for Asians. A comprehensive measure of adiposity will further our understanding of the role of obesity in the development of pancreas cancer.
In summary, unlike the findings in western countries, we found no overall association between BMI and the risk of death from pancreas cancer in the pooled analysis of Asian men and women. With the increasing prevalence of overweight and obesity and type-II diabetes in Asians (Yoon et al., 2006) , additional studies will be required to further address this possible association.
